Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.44 | 0.1 |
mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.43 | 0.004 |
mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.4 | 0.01 |
mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.31 | 0.07 |
mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.23 | 4e-05 |
mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |